Used in pharmaceutical synthesis as a key intermediate for developing bioactive molecules, particularly in the production of selective receptor modulators. Its structural features enable effective binding in medicinal chemistry applications, especially in central nervous system agents and metabolic disease treatments. The presence of functional groups like hydroxymethyl and fluorinated aryl moieties enhances metabolic stability and target specificity. Commonly employed in asymmetric synthesis to construct complex pyrrolidine-based drug candidates.